Chemistree Technology Inc. CHMJF Archives

TuesdayOct 08, 2019 10:02 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Cancellation of PCCBD Investment

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Monday announced termination of the proposed investment into The Physician's Choice CBD ("PCCBD") of Phoenix, Arizona, as previously disclosed in April 2019. “I am disappointed to report that after many months of meetings, discussions and attempts to manage an increasingly frustrating process, Chemistree has decided that the proposed $1 million investment into what we believed was a compelling and unique company, cannot be made,” Chemistree President Karl Kottmeier said in the news release. “While scientifically excellent, our due diligence identified significant issues with PCCBD management. We ultimately determined that we could not arrive…

FridaySep 27, 2019 9:46 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Voices Support of SAFE Banking Act

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Thursday announced its support for the passage of the Secure and Fair Enforcement Banking Act of 2019 (“SAFE Banking Act”) by the United States House of Representatives. The SAFE Banking Act is anticipated to be voted on by the U.S. Senate by the end of the year. “Chemistree decided early in its history to focus on developing its business in the legal cannabis industry in certain states in the US. Members of our management team, our Board of Directors and major shareholders have long been significant influencers in the legal cannabis industry in…

TuesdaySep 24, 2019 10:08 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Posts Update on Washington State Assets

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning posted a shareholder update regarding its Washington State assets. Per the update, the company received an encouraging report from the general manager of its Washington state licensee partner that detailed increases from April of 30% in sales, 36% in crop yield and 100% in retail client stores. Chemistree also announced that Sugarleaf requested extra cultivation facilities at the Sedro Wooley location, on the same turn-key basis as currently in place, so it can double its current capacity and meet the quickly growing demand for Sugarleaf branded products. “These numbers are surpassing my…

MondayJul 22, 2019 10:31 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Completes Investment in Applied Cannabis Sciences of New Jersey

Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that, through a wholly owned U.S. subsidiary, it has finalized its investment into Applied Cannabis Sciences of New Jersey ("ACS"). The investment was previously announced in an April 15, 2019, press release as a letter of intent. According to the update, ACS will submit its application in the upcoming New Jersey round of Request for Applications (“RFA”), through which the state will issue 24 new permits comprising of 15 dispensary permits, 5 cultivation permits and 4 vertically integrated permits. "Completing this investment with ACS and being on the ground floor…

MondayJun 10, 2019 10:35 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Partner ACS to File NJ Application Under New DOH Program

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning announced that its partner, Applied Cannabis Sciences of New Jersey ("ACS"), is preparing an application under the Department of Health’s new Request for Applications (“RFA”) program. According to the update, the Department will seek up to 24 cultivation, 30 manufacturing and 54 dispensary endorsements. ACS will apply for all three permit types, as allowable, creating a vertically integrated business model. “When we entered discussions to participate with ACS, we were particularly impressed by the team of industry experts they had assembled, and their deep local knowledge of the dynamic, developing New Jersey…

MondayApr 29, 2019 10:12 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) Enters Agreement to Acquire Ownership Stake in The Physician’s Choice CBD LLC

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) this morning announced its entry into a funding agreement with The Physician's Choice CBD LLC (“PCCBD”) of Phoenix, Arizona, which is dedicated to researching, developing and utilizing the highest quality of hemp-derived cannabidiol (“CBD”) in combination with well-studied and effective supplements to assist in supporting and regulating various symptoms. "This investment in The Physician's Choice CBD is a great opportunity for Chemistree,” Chemistree President Karl Kottmeier commented in the news release. “Dr. Grove and Dr. Kubitz are board certified practicing physicians with training at Harvard and the Mayo Clinic, specializing in pain management.…

ThursdayApr 18, 2019 10:27 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Issues Shareholder Update on Washington Operations and California Cultivation Facility

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning provided an update to shareholders on its Washington state assets and Desert Hot Springs, California cultivation facility development. Per the update, Chemistree’s Washington state licensee partner has confirmed further advancements in crucial areas of its cultivation facility, including the appointment of key staff; upgrading of 288 on hand grow lights in flower and sale of retrofitted lights, with new lights expected to improve crop yields by 20 percent or more; retail points of sale expansion of 25 percent, offering Sugarleaf products; increase of product SKUs by 20 percent, with new products including…

MondayApr 15, 2019 10:58 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Partners with NJ Medical Retail Cannabis License Applicant

Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that its wholly owned U.S. subsidiary, American CHM Investments Inc., has entered a letter of intent to partner with Applied Cannabis Sciences of New Jersey ("ACS"), a New Jersey-based medical retail dispensary applicant in the state’s upcoming round of request for applications, which is anticipated in 2020. ACS’s leadership team combines seasoned professionals from the legal medicinal and adult use marijuana industry with over 50 years of collective experience and includes over 20 cultivation, processing and manufacturing licenses across four U.S. states (Washington, Oregon, California and Colorado). "We are excited…

ThursdayApr 11, 2019 10:43 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Industry Expert as Chief Cannabis Officer

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning announced its appointment of Sheldon Aberman to the newly-created position of chief cannabis officer. According to the update, Aberman is one of the world's foremost experts on commercial cannabis cultivation, with expertise, a hands-on approach and product development background as well as decades of experience managing and designing thousands of grows worldwide. “Sheldon is not only a Chemistree Director, but also one of the founders of Chemistree. He has been integral to the Company, overseeing our investment in Washington State, the expansion of our Sugarleaf brand, and the successful receipt of the…

TuesdayApr 09, 2019 9:00 am

QualityStocksNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Cannabis Industry Veteran with Passion, Deep Expertise to its Board

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) recently announced its appointment of Nicholas J. Zitelli to its board of directors. Zitelli is currently part-owner, director, and chief cannabis officer of Trans High Corporation (“THC”), the parent company for all HIGH TIMES brands, and is also the founder and CEO of the Cannabis Genetics Institute (“CGI”), a well-established research and development institution. Zitelli has authored hundreds of articles since 2007, under the penname of "Nico Escondido,” covering all cannabis science and technology aspects and garnering a reputation as an industry expert in the areas of garden technologies, cultivation, genetics, lab testing, and…

Site Search

Company Search

Tag: Chemistree Technology Inc. CHMJF